Anti-IPO 38 antibody [IPO38] - Proliferation Marker,Abcam,AB190704

ab190704 recognizes a protein of 14-16kDa, which is a novel nuclear antigen of proliferating cells. IPO 38 antigen is present in the nuclei of proliferating cells such as Hodgkin's disease and non-Hodgkin's lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO 38 can be a useful marker of cell proliferation during monitoring of tumor progression.

Host

Mouse

Reactivity

Mouse, Rat, Human

Application

ICC/IF, IHC-P, IHC-Fr

Platform ID

BAB171328281

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-IPO 38 antibody [IPO38] - Proliferation Marker
Cat. No.AB190704
HostMouse
IsotypeIgM
ReactivityMouse, Rat, Human
ApplicationICC/IF, IHC-P, IHC-Fr
ClonalityMonoclonal
Clone NumberIPO38
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.05% Sodium azide
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data See full target information IPO 38

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.